全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

中性粒淋巴细胞比值与心血管疾病关系研究进展
Advances in the Relationship between Neutrophil Lymphocyte Ratio and Cardiovascular Disease

DOI: 10.12677/ACM.2023.133451, PP. 3173-3177

Keywords: 中性粒与淋巴细胞比值,心血管疾病,预后,综述
Neutrophil-to-Lymphocyte Ratio
, Cardiovascular Disease, Prognosis, Review

Full-Text   Cite this paper   Add to My Lib

Abstract:

中性粒淋巴细胞比值(NLR)作为一种简便,可靠,容易获取的复合性指标逐渐在心血管,肿瘤学科领域上被学者关注。越来越多的研究证实NLR与多种心血管疾病发病,发展及其预后相关。本文主要综述NLR与冠状动脉粥样硬性心脏病,高血压,心律失常,心力衰竭,心脏瓣膜病病因及预后的关系,以便临床工作者对此类高危险患者早识别早干预,预防患者并发症,改善患者预后。
Neutrophil lymphocyte ratio (NLR) is gaining attention as a simple, reliable, and easily accessible composite index in the field of cardiovascular and oncology. An increasing number of studies have confirmed the association of NLR with the pathogenesis, development and prognosis of various car-diovascular diseases. This article reviews the relationship between NLR and the etiology and prog-nosis of atherosclerotic heart disease, hypertension, arrhythmias, heart failure, and heart valve disease, in order to facilitate early identification and intervention of such high-risk patients, pre-vent complications, and improve their prognosis by clinical workers.

References

[1]  Kawada, T. (2019) Socioeconomic Status and Cardiovascular Disease. International Journal of Cardiology, 274, 378.
https://doi.org/10.1016/j.ijcard.2018.07.034
[2]  Yang, G., et al. (2013) Rapid Health Transition in China, 1990-2010: Findings from the Global Burden of Disease Study 2010. The Lancet, 381, 1987-2015.
https://doi.org/10.1016/S0140-6736(13)61097-1
[3]  Welsh, C., et al. (2018) Association of Total and Differential Leukocyte Counts with Cardiovascular Disease and Mortality in the UK Biobank. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, 1415-1423.
https://doi.org/10.1161/ATVBAHA.118.310945
[4]  Kahraman, S., et al. (2021) The Neutrophil to Lymphocyte Ratio (NLR) Is Associated with Residual Syntax Score in Patients with ST-Segment Elevation Myocardial Infarction. Angiology, 72, 166-173.
https://doi.org/10.1177/0003319720958556
[5]  Golia, E., et al. (2014) Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target. Current Atherosclerosis Reports, 16, 435.
https://doi.org/10.1007/s11883-014-0435-z
[6]  Nú?ez, J., et al. (2008) Usefulness of the Neutrophil to Lympho-cyte Ratio in Predicting Long-Term Mortality in ST Segment Elevation Myocardial Infarction. American Journal of Car-diology, 101, 747-752.
https://doi.org/10.1016/j.amjcard.2007.11.004
[7]  Haybar, H., Pezeshki, S.M.S. and Saki, N. (2019) Evaluation of Complete Blood Count Parameters in Cardiovascular Diseases: An Early Indicator of Prognosis? Experimental and Mo-lecular Pathology, 110, Article ID: 104267.
https://doi.org/10.1016/j.yexmp.2019.104267
[8]  Canpolat, U., et al. (2013) Role of Preablation Neutro-phil/Lymphocyte Ratio on Outcomes of Cryoballoon-Based Atrial Fibrillation Ablation. American Journal of Cardiology, 112, 513-519.
https://doi.org/10.1016/j.amjcard.2013.04.015
[9]  Weber, C. and Noels, H. (2011) Atherosclerosis: Current Pathogenesis and Therapeutic Options. Nature Medicine, 17, 1410-1422.
https://doi.org/10.1038/nm.2538
[10]  Balta, S., et al. (2015) The Relation between Atherosclerosis and the Neutro-phil-Lymphocyte Ratio. Clinical and Applied Thrombosis/Hemostasis, 22, 405-411.
https://doi.org/10.1177/1076029615569568
[11]  Choi, D.H., et al. (2019) Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events after Percutaneous Cor-onary Intervention. Angiology, 70, 345-351.
https://doi.org/10.1177/0003319718768658
[12]  Dentali, F., et al. (2018) Impact of Neutrophils to Lymphocytes Ratio on Major Clinical Outcomes in Patients with Acute Coronary Syndromes: A Systematic Review and Meta-Analysis of the Literature. International Journal of Cardiology, 266, 31-37.
https://doi.org/10.1016/j.ijcard.2018.02.116
[13]  Verdoia, M., et al. (2016) Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study. Angiology, 67, 75-82.
https://doi.org/10.1177/0003319715577529
[14]  Oncel, R.C., et al. (2015) Relation of Neutrophil-to-Lymphocyte Ratio with GRACE Risk Score to In-Hospital Cardiac Events in Patients with ST-Segment Elevated Myocardial Infarc-tion. Clinical and Applied Thrombosis/Hemostasis, 21, 383-388.
https://doi.org/10.1177/1076029613505763
[15]  Wada, H., et al. (2017) Pre-Procedural Neutrophil-to-Lymphocyte Ratio and Long-Term Cardiac Outcomes after Percutaneous Coronary Intervention for Stable Coronary Artery Disease. Atherosclerosis, 265, 35-40.
https://doi.org/10.1016/j.atherosclerosis.2017.08.007
[16]  Bressi, E., et al. (2018) Impact of Neutro-phil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio on 5-Year Clinical Outcomes of Patients with Stable Coro-nary Artery Disease Undergoing Elective Percutaneous Coronary Intervention. Journal of Cardiovascular Translational Research, 11, 517-523.
https://doi.org/10.1007/s12265-018-9829-6
[17]  Dinh, Q.N., et al. (2014) Roles of In-flammation, Oxidative Stress, and Vascular Dysfunction in Hypertension. BioMed Research International, 2014, Article ID: 406960.
https://doi.org/10.1155/2014/406960
[18]  Barrows, I.R., Ramezani, A. and Raj, D.S. (2019) Inflam-mation, Immunity, and Oxidative Stress in Hypertension—Partners in Crime? Advances in Chronic Kidney Disease, 26, 122-130.
https://doi.org/10.1053/j.ackd.2019.03.001
[19]  Liu, X., et al. (2015) Blood Neutrophil to Lymphocyte Ratio as a Predictor of Hypertension. American Journal of Hypertension, 28, 1339-1346.
https://doi.org/10.1093/ajh/hpv034
[20]  Jhuang, Y.H., et al. (2019) Neutrophil to Lymphocyte Ratio as Predictor for Incident Hypertension: A 9-Year Cohort Study in Taiwan. Hypertension Research, 42, 1209-1214.
https://doi.org/10.1038/s41440-019-0245-3
[21]  Cimen, T., et al. (2017) The Relationship between 24-Hour Am-bulatory Blood Pressure Load and Neutrophil-to-Lymphocyte Ratio. Revista Portuguesa de Cardiologia, 36, 97-105.
https://doi.org/10.1016/j.repc.2016.07.009
[22]  Sun, X., et al. (2017) The Neutrophil-to-Lymphocyte Ratio on Admission Is a Good Predictor for All-Cause Mortality in Hypertensive Patients over 80 Years of Age. BMC Cardio-vascular Disorders, 17, 167.
https://doi.org/10.1186/s12872-017-0595-1
[23]  Karatas, M.B., et al. (2016) Association of Admission Serum La-boratory Parameters with New-Onset Atrial Fibrillation after a Primary Percutaneous Coronary Intervention. Coronary Artery Disease, 27, 128-134.
https://doi.org/10.1097/MCA.0000000000000333
[24]  Akdag, S., et al. (2015) Association of Epicardial Adipose Tissue Thickness and Inflammation Parameters with CHA2DS2-VASASc Score in Patients with Nonvalvular Atrial Fi-brillation. Therapeutics and Clinical Risk Management, 11, 1675-1681.
https://doi.org/10.2147/TCRM.S94955
[25]  Weymann, A., et al. (2018) Haematological Indices as Predictors of Atrial Fibrillation Following Isolated Coronary Artery Bypass Grafting, Valvular Surgery, or Combined Procedures: A Systematic Review with Meta-Analysis. Kardiologia Polska, 76, 107-118.
https://doi.org/10.5603/KP.a2017.0179
[26]  Chen, Y., et al. (2020) Diagnostic Value of MR-proANP for Heart Failure in Patients with Acute Dyspnea: A Meta-Analysis. Acta Cardiologica, 75, 68-74.
https://doi.org/10.1080/00015385.2018.1550887
[27]  Sundararajan, S., et al. (2019) The Neutrophil-Lymphocyte Ratio and Survival during Left Ventricular Assist Device Support. Journal of Cardiac Failure, 25, 188-194.
https://doi.org/10.1016/j.cardfail.2019.01.005
[28]  Wan, G., et al. (2018) Screening Genes Associated with Ele-vated Neutrophil-to-Lymphocyte Ratio in Chronic Heart Failure. Molecular Medicine Reports, 18, 1415-1422.
https://doi.org/10.3892/mmr.2018.9132
[29]  Karag?z, A., Vural, A., Günayd?n, Z.Y., Bekta?, O., Gül, M., ?elik, A., Uzuno?lu, E., Usta, S., Sar?ta?, A. and Elalm??, ?.U. (2015) The Role of Neutrophil to Lymphocyte Ratio as a Pre-dictor of Diastolic Dysfunction in Hypertensive Patients. European Review for Medical and Pharmacological Sciences, 19, 433-440.
[30]  Durmus, E., et al. (2015) Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Predictors of Heart Failure. Molecular Medicine Reports, 105, 606-613.
https://doi.org/10.5935/abc.20150126
[31]  Avci, A., et al. (2014) Neutrophil/Lymphocyte Ratio Is Related to the Severity of Idiopathic Dilated Cardiomyopathy. Scandinavian Cardiovascular Journal, 48, 202-208.
https://doi.org/10.3109/14017431.2014.932922
[32]  Khalil, C., et al. (2018) Neutrophil-to-Lymphocyte Ratio Pre-dicts Heart Failure Readmissions and Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. Indian Heart Journal, 70, S313-S318.
https://doi.org/10.1016/j.ihj.2018.08.002
[33]  Polat, N., et al. (2014) Association of Neutrophil-Lymphocyte Ratio with the Presence and Severity of Rheumatic Mitral Valve Stenosis. Clinical and Applied Thrombosis/Hemostasis, 20, 793-798.
https://doi.org/10.1177/1076029613514131
[34]  Celik, S.F. and Celik, E. (2018) The Neutrophil-to-Lymphocyte Ratio and Mean Platelet Volume Can Be Associated with Severity of Valvular Involvement in Patients with Acute Rheumatic Carditis. Cardiovascular Journal of Africa, 29, 296-300.
https://doi.org/10.5830/CVJA-2018-031
[35]  Sinan Guvenc, T., et al. (2016) Prognostic Value of Neutro-phil-to-Lymphocyte Ratio for Patients Undergoing Heart Valve Replacement. Journal of Heart Valve Disease, 25, 389-396.
[36]  Separham, A., et al. (2017) Predicting Outcome after Percutaneous Balloon Mitral Commissurotomy: Role of Neutrophil-Lymphocyte Ratio. Herz, 42, 509-514.
https://doi.org/10.1007/s00059-016-4488-3

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133